Labeling Gaffe Sparks Mylan Drug Recall In Canada

Law360, New York (March 18, 2011, 3:21 PM EDT) -- Mylan Pharmaceuticals Inc.'s Canadian unit said Thursday it is voluntarily recalling some bottles of its Minocycline antibiotic drug and its Amlodipine hypertension drug because of a labeling mix-up reported by a pharmacist.

The recall includes all 100-count bottles of Mylan-Minocycline and Mylan-Amlodipine with product lot number 1037180 that were distributed to wholesalers and pharmacies, but does not include 250-count bottles carrying the same lot number, Mylan Pharmaceuticals ULC in Canada said.

Mylan launched the product call-back after a pharmacist who had received several bottles of Mylan-Minocycline...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.